Cancer diagnostics integrated with therapeutics: Comprehensive approach to managing the disease

Journal of Biomedicine and Biotechnology

Volumn 2004, Issue 4, 2004, Pages 175-176

  Ghanbari, Hossein A ^{a,b,c,d,e,f,g,h,i,j,k,l}  

^a Panacea Pharmaceuticals Inc   (United States)

^b CEO CSO   (United States)

^c Panacea Pharmaceuticals   (United States)

^d Alzheimer's Corporation   (United States)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

^g ABBOTT LABORATORIES   (United States)

^h NDA Team   (United States)

ⁱ Abbott's Technical Advisory Board   (United States)

^j Volwiler Society   (United States)

^k Molecular Geriatrics Corporation   (United States)

^l UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINYL BETA HYDROXYLASE; ASPARTYL BETA HYDROXYLASE; ENZYME; OXYGENASE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

CANCER CONTROL; CANCER DIAGNOSIS; CANCER THERAPY; DISEASE MARKER; EARLY DIAGNOSIS; EDITORIAL; PROSTATE CANCER;

EID: 12344321540     PISSN: 11107243     EISSN: None     Source Type: Journal    
DOI: 10.1155/S1110724304408031     Document Type: Editorial

References (0)